Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Fascicoli precedenti > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 October;56(5)

ULTIMO FASCICOLOTHE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Rivista di Medicina Nucleare e Imaging Molecolare


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413


Periodicità: Trimestrale

ISSN 1824-4785

Online ISSN 1827-1936


eTOC

 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 October;56(5)

 AN UPDATE ON MOLECULAR IMAGING OF PROSTATE CANCER (Part II) 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 October;56(5):409-20

Treatment of recurrent prostate cancer following radical prostatectomy: the radiation-oncologists point of view

Rischke H. C., Knippen S., Kirste S., Grosu A. L.


 AN UPDATE ON MOLECULAR IMAGING OF PROSTATE CANCER (Part II) 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 October;56(5):421-9

Lymph nodal metastases: diagnosis and treatment

Di Muzio N., Fodor A., Berardi G., Mapelli P., Gianolli L., Messa C., Picchio M.


 AN UPDATE ON MOLECULAR IMAGING OF PROSTATE CANCER (Part II) 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 October;56(5):430-9

[11C]Choline-PET/CT for outcome prediction of salvage radiotherapy of local relapsing prostate carcinoma

Reske S. N., Moritz S., Kull T.


 AN UPDATE ON MOLECULAR IMAGING OF PROSTATE CANCER (Part II) 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 October;56(5):440-6

Correlation of [11C]choline PET-CT with time to treatment and disease-specific survival in men with recurrent prostate cancer after radical prostatectomy

Breeuwsma A. J., Rybalov M., Leliveld A. M., Pruim J., de Jong I. J.


 AN UPDATE ON MOLECULAR IMAGING OF PROSTATE CANCER (Part II) 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 October;56(5):447-58

Imaging of bone metastases in prostate cancer: an update

Langsteger W., Haim S., Knauer M., Waldenberger P., Emmanuel K., Loidl W., Wolf I., Beheshti M.


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 October;56(5):459-67

Role of low-cost thyroid follow-up in children treated with radiotherapy for primary tumors at high risk of developing a second thyroid tumor

Piccardo A., Foppiani L., Puntoni M., Hanau G., Calafiore L., Garaventa A., Arlandini A., Villavecchia G., Bianchi P., Cabria M.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 October;56(5):468-75

Improving radiopeptide pharmacokinetics by adjusting experimental conditions for bombesin receptor-targeted imaging of prostate cancer

Schroeder R. P. J., De Blois E., De Ridder C. M. A., Van Weerden W. M., Breeman W. A. P., de Jong M.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 October;56(5):476-84

The widened use of exogenous stimulation with recombinant human TSH to treat metastatic thyroid carcinoma in Italy

Maffioli L., Florimonte L., Fugazzola L., Banti E., Bagnasco M., Dottorini M. E., Perotti G., Rubello D., Seregni E., Bombardieri E., Testori O.


inizio pagina